Why is greater medication adherence associated with better outcomes

Emerging Themes in Epidemiology

Volumn 10, Issue 1, 2013, Pages

  Hartz, Arthur ^a   He, Tao ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Adherence; Confounding; Observational studies; Placebo; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CEREBROVASCULAR ACCIDENT; COLON CANCER; DEATH; FEMALE; HEALTH CARE; HEART INFARCTION; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RISK FACTOR; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 84873047820     PISSN: None     EISSN: 17427622     Source Type: Journal    
DOI: 10.1186/1742-7622-10-1     Document Type: Article

References (19)

1. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. The Coronary Drug Project Research Group, N Engl J Med 1980 303 1038 1041 6999345
2. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA, Lancet 2005 366 2005 2011 10.1016/S0140-6736(05)67760-4 16338449 (Pubitemid 41773375)
3. An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey. Granger AL, Fehnel SE, Hogue SL, Bennett L, Edin HM, J Affect Disord 2006 90 217 221 10.1016/j.jad.2005.08.018 16360216 (Pubitemid 43183531)
4. Treatment adherence and risk of death after a myocardial infarction. Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, Ransohoff DF, Sindelar J, Lancet 1990 336 542 545 10.1016/0140-6736(90)92095-Y 1975045 (Pubitemid 20278106)
5. A meta-analysis of the association between adherence to drug therapy and mortality. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA, BMJ 2006 333 15 10.1136/bmj.38875.675486.55 16790458
6. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. Shrank WH, Patrick AR, Brookhart MA, J Gen Intern Med 2011 26 546 550 10.1007/s11606-010-1609-1 21203857
7. Healthy users, healthy adherers, and healthy behaviors. Silverman SL, Gold DT, J Bone Miner Res 2011 26 681 682 10.1002/jbmr.384 21433070
8. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Brookhart MA, Patrick AR, Schneeweiss S, Avorn J, Dormuth C, Shrank W, van Wijk BL, Cadarette SM, Canning CF, Solomon DH, Arch Intern Med 2007 167 847 852 10.1001/archinte.167.8.847 17452550 (Pubitemid 46658345)
9. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E, Medical care 2009 47 334 341 10.1097/MLR.0b013e31818afa1c 19194337
10. Statin use and risk of community acquired pneumonia in older people: population based case-control study. Dublin S, Jackson ML, Nelson JC, Weiss NS, Larson EB, Jackson LA, BMJ 2009 338 2137 10.1136/bmj.b2137 19531550
11. Statin adherence and risk of accidents: a cautionary tale. Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA, Circulation 2009 119 2051 2057 10.1161/CIRCULATIONAHA.108.824151 19349320
12. Design of the Women's Health Initiative clinical trial and observational study. Women's Health Initiative Study Group, Control Clin Trials 1998 19 61 109 9492970
13. Implementation of the Women's Health Initiative study design. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL, Ann Epidemiol 2003 13 5 S17 10.1016/S1047-2797(03)00043-7 14575938 (Pubitemid 37324175)
14. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, Daugherty S, Ann Epidemiol 2003 13 122 S128 10.1016/S1047-2797(03)00048-6 14575944 (Pubitemid 37324181)
15. No Adjustments Are Needed for Multiple Comparisons. Rothman KJ, Epidemiology 1990 1 43 46 10.1097/00001648-199001000-00010 2081237 (Pubitemid 20255621)
16. Adherence and arrhythmic mortality in the cardiac arrhythmia suppression trial (CAST). Obias-Manno D, Friedmann E, Brooks MM, Thomas SA, Haakenson C, Morris M, Wimbush F, Somelofski C, Goldner F, Ann Epidemiol 1996 6 93 101 8775589 (Pubitemid 26097393)
17. The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial. Curtis JR, Delzell E, Chen L, Black D, Ensrud K, Judd S, Safford MM, Schwartz AV, Bauer DC, Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 2011 26 683 688 10.1002/jbmr.274
18. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors. Cadarette SM, Solomon DH, Katz JN, Patrick AR, Brookhart MA, Osteoporos Int 2011 22 943 954 10.1007/s00198-010-1309-z 20532481
19. Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials. Curtis JR, Larson JC, Delzell E, Brookhart MA, Cadarette SM, Chlebowski R, Judd S, Safford M, Solomon DH, Lacroix AZ, Med Care 2011 49 427 435 10.1097/MLR.0b013e318207ed9e 21422960